Omkar Speciality Chemicals Announces Capital Restructuring Plan Under Insolvency Resolution Process
Omkar Speciality Chemicals Limited has announced a five-step capital restructuring plan under its insolvency resolution process. The plan includes complete capital reduction to NIL per NCLT order dated July 31, 2025, fresh equity issuance to Resolution Applicant at INR 10 face value, and achieving minimum public shareholding through 5% OFS mechanism. The company will seek stock exchange approvals before implementing the share allotment process.

*this image is generated using AI for illustrative purposes only.
Omkar Speciality Chemicals Limited, currently under the Corporate Insolvency Resolution Process (CIRP), has announced a comprehensive restructuring plan following its approved Resolution Plan under the Insolvency and Bankruptcy Code, 2016. The company was admitted into CIRP via order dated December 5, 2022.
Capital Restructuring Framework
The restructuring plan encompasses five key steps designed to reorganize the company's capital structure and ensure regulatory compliance. The plan was communicated to both BSE Limited and National Stock Exchange of India Limited on April 28, 2026, by Ajit Kumar, Chairperson of the Monitoring Committee.
| Step | Action | Details |
|---|---|---|
| 1 | Capital Reduction | Entire share capital to be reduced to NIL |
| 2 | Fresh Equity Issuance | New shares at INR 10 face value to Resolution Applicant |
| 3 | Exchange Approval | In-principle approval from stock exchanges |
| 4 | Share Allotment | Resolution Applicant to hold 100% paid-up capital |
| 5 | Public Shareholding | 5% OFS to achieve minimum public shareholding |
Implementation Timeline and Process
The capital reduction will be executed as per the Hon'ble NCLT order dated July 31, 2025, which mandates the complete reduction of the company's existing share capital to NIL. Following this, the company will pass an enabling resolution in the Monitoring Committee meeting to authorize the issuance of fresh equity shares with a face value of INR 10 each to the Resolution Applicant.
Regulatory Compliance Measures
To ensure compliance with SEBI regulations, the company will file applications with stock exchanges for obtaining in-principle approval for the proposed issue and allotment of equity shares. Post-approval, the company will circulate a letter of offer to the Resolution Applicant, who will then subscribe to the fresh equity shares at face value.
Minimum Public Shareholding Achievement
In the final phase, the company will undertake an Offer for Sale (OFS) of 5% of equity shares held by the promoter/promoter group through the stock exchange mechanism. This step is specifically designed to ensure compliance with SEBI's Minimum Public Shareholding requirements.
The restructuring plan represents a significant milestone in the company's insolvency resolution process, providing a clear roadmap for capital reorganization and regulatory compliance under the monitoring of the appointed committee.
Who is the Resolution Applicant that will acquire 100% ownership, and what are their plans for the company's operations?
How will the complete capital reduction to NIL impact existing shareholders' rights and potential compensation?
What valuation methodology will be used for the 5% OFS to achieve minimum public shareholding compliance?



























